R
Richard Pötter
Researcher at Medical University of Vienna
Publications - 398
Citations - 21322
Richard Pötter is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Brachytherapy & Cervical cancer. The author has an hindex of 67, co-authored 390 publications receiving 17921 citations.
Papers
More filters
Journal ArticleDOI
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
Richard Pötter,Christine Haie-Meder,Erik Van Limbergen,Isabelle Barillot,Marisol De Brabandere,Johannes Dimopoulos,Isabelle Dumas,Beth Erickson,Stefan Lang,A. Nulens,Peter Petrow,Jason Rownd,Christian Kirisits +12 more
TL;DR: It is expected that the therapeutic ratio including target coverage and sparing of organs at risk can be significantly improved, if radiation dose is prescribed to a 3D image-based CTV taking into account dose volume constraints for OAR.
Journal ArticleDOI
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
Christine Haie-Meder,Richard Pötter,Erik Van Limbergen,E. Briot,Marisol De Brabandere,Johannes Dimopoulos,Isabelle Dumas,Taran Paulsen Hellebust,Christian Kirisits,Stefan Lang,Sabine Muschitz,Juliana Nevinson,A. Nulens,Peter Petrow,Natascha Wachter-Gerstner +14 more
TL;DR: The recommendations described in this report were proposed based on clinical experience and dosimetric concepts of different institutions (IGR, Leuven, Vienna) and were stepwise validated against the background of different clinical experience.
Journal ArticleDOI
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
Richard Pötter,Petra Georg,Johannes Dimopoulos,Magdalena Grimm,Daniel Berger,Nicole Nesvacil,Dietmar Georg,Maximilian Schmid,Alexander Reinthaller,Alina Sturdza,Christian Kirisits +10 more
TL;DR: 3D conformal radiotherapy ± chemotherapy plus image (MRI) guided adaptive intracavitary brachytherapy including needle insertion in advanced disease results in local control rates of 95–100% at 3 years in limited/favourable (IB/IIB) and 85–90% in large/poor response (IIB/III/IV) cervix cancer patients associated with a moderate rate of treatment related morbidity.
Journal ArticleDOI
Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
Csaba Polgár,Erik Van Limbergen,Richard Pötter,György Kovács,Alfredo Polo,J. Lyczek,Guido Hildebrandt,Peter Niehoff,Jose Luis Guinot,Ferran Guedea,Bengt Johansson,Oliver J. Ott,Tibor Major,Vratislav Strnad +13 more
TL;DR: Recommendations will provide clinical guidance regarding the use of APBI outside the context of a clinical trial before large-scale randomized clinical trial outcome data become available and should promote further clinical research focusing on controversial issues in the treatment of early-stage breast carcinoma.
Journal ArticleDOI
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.
Vratislav Strnad,Oliver J. Ott,Guido Hildebrandt,Daniela Kauer-Dorner,Hellen Knauerhase,Tibor Major,J. Lyczek,Jose Luis Guinot,Jürgen Dunst,Cristina Gutierrez Miguelez,Pavel Šlampa,Michael Allgäuer,Kristina Lössl,Bülent Polat,György Kovács,Arnt-René Fischedick,Thomas G. Wendt,Rainer Fietkau,Marion Hindemith,Alexandra Resch,Anna Kulik,Leo Arribas,Peter Niehoff,Fernando Guedea,Annika Schlamann,Richard Pötter,Christine M. Gall,Martina Malzer,Wolfgang Uter,Csaba Polgár +29 more
TL;DR: Adjuvant APBI using multicatheter brachytherapy after breast-conserving surgery in patients with early breast cancer is not inferior to adjuvant whole-breast irradiation with respect to 5-year local control, disease-free survival, and overall survival.